News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
898,308 Results
Type
Article (89686)
Company Profile (646)
Press Release (807952)
Multimedia
Podcasts (284)
Webinars (44)
Section
Business (267519)
Career Advice (4177)
Deals (40164)
Drug Delivery (246)
Drug Development (92157)
Employer Resources (212)
FDA (18741)
Job Trends (17563)
News (399643)
Policy (40038)
Tag
2025 Best Places to Work (25)
2026 Best Places to Work (39)
2027 BioCapital Standard (5)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (7)
2027 Genetown Elite (2)
2027 Genetown Standard (6)
2027 NextGen (6)
2027 Pharm Country Digital (4)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
40 Under 40 (4)
Academia (3112)
Academic (2)
Accelerated approval (77)
ADA (54)
Adcomms (44)
Allergies (237)
Alliances (57000)
ALS (293)
Alzheimer's disease (2159)
Antibody-drug conjugate (ADC) (780)
Approvals (19340)
Artificial intelligence (1149)
ASCO (350)
Autoimmune disease (538)
Automation (84)
Bankruptcy (414)
Belgium (45)
Best Places to Work (12636)
BIO (84)
Biologics (121)
BIOSECURE Act (23)
Biosimilars (309)
BioSpace Insights (271)
Biotechnology (340)
Bispecific (61)
Bladder cancer (253)
Brain cancer (104)
Breast cancer (983)
Cancer (8084)
Cardiovascular disease (685)
Career advice (3639)
Career pathing (65)
CAR-T (465)
CDC (82)
CDMO (238)
Celiac Disease (7)
Cell-line development (2)
Cell therapy (1281)
Cervical cancer (69)
Clinical research (81268)
Collaboration (2899)
Commercialization (77)
Company closure (10)
Compensation (1943)
Complete response letters (129)
COVID-19 (3089)
CRISPR (155)
CRO (9)
C-suite (1717)
Cystic fibrosis (183)
Data (11205)
Decentralized trials (4)
Denatured (112)
Depression (230)
Dermatology (209)
Diabetes (855)
Diagnostics (7956)
Digital health (87)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (568)
Drug pricing (255)
Drug shortages (41)
Duchenne muscular dystrophy (389)
Earnings (104820)
Editorial (85)
Employer branding (27)
Employer resources (184)
ESMO (441)
Events (142025)
Executive appointments (1386)
Eye disease (28)
FDA (23884)
Fibrodysplasia Ossificans Progressiva (17)
Fragile X (6)
Friedreich's ataxia (29)
Frontotemporal dementia (43)
Funding (2392)
Gene editing (323)
Generative AI (116)
Gene therapy (991)
GLP-1 (1418)
Government (5636)
Grass and pollen (8)
Guidances (446)
Healthcare (21527)
Hematology (238)
HIV (128)
Huntington's disease (93)
Idiopathic pulmonary fibrosis (16)
IgA nephropathy (155)
Immunology and inflammation (432)
Immuno-oncology (166)
Indications (299)
Infectious disease (3551)
Inflammatory bowel disease (285)
Inflation Reduction Act (17)
Influenza (168)
Intellectual property (391)
Interviews (830)
IPO (18072)
IRA (61)
Job creations (5211)
Job search strategy (2882)
JPM (73)
Kidney cancer (32)
Kidney disease (183)
Labor market (152)
Layoffs (733)
Leadership (70)
Legal (10180)
Licensing (132)
Liver cancer (121)
Longevity (58)
Lung cancer (1113)
Lung diease (27)
Lymphoma (570)
Machine learning (78)
Management (72)
Manufacturing (1664)
Marketing (42)
MASH (260)
Medical affairs (5)
Medical device (15491)
Medtech (15829)
Mergers & acquisitions (23656)
Metabolic disorders (2179)
Middle East (2)
mRNA (345)
Multiple sclerosis (263)
Multispecific (7)
NASH (24)
Netherlands (42)
Neurodegenerative disease (638)
Neuropsychiatric disorders (155)
Neuroscience (4381)
Neurotech (4)
NextGen: Class of 2026 (7718)
Non-profit (5176)
Now hiring (101)
Obesity (1030)
Opinion (411)
Ovarian cancer (301)
Pain (353)
Pancreatic cancer (459)
Parkinson's disease (497)
Partnered (53)
Patents (818)
Patient advocacy (8)
Patient recruitment (988)
Patient selection (118)
Peanut (81)
People (69177)
Peptides (46)
Pharmaceutical (83)
Pharmacy benefit managers (43)
Phase 1 (25063)
Phase 2 (35302)
Phase 3 (26607)
Pipeline (14732)
Policy (435)
Postmarket research (3561)
Preclinical (11214)
Press Release (74)
Prostate cancer (414)
Psychedelics (105)
Radioligand (3)
Radiopharmaceuticals (449)
Rare diseases (1619)
Real estate (7479)
Recruiting (84)
Regenerative medicine (38)
Regulatory (31924)
Reports (104)
Research institute (2823)
Resumes & cover letters (657)
Rett syndrome (60)
RNA editing (39)
RSV (107)
Saudi Arabia (1)
Schizophrenia (231)
Series A (411)
Series B (287)
Service/supplier (17)
Sickle cell disease (153)
Special edition (38)
Spinal muscular atrophy (201)
Sponsored (61)
Startups (4408)
State (2)
Stem cells (8)
Stomach cancer (24)
Substance use disorders (23)
Supply chain (173)
Switzerland (25)
Tariffs (108)
Tax incentives (2)
The Weekly (169)
Vaccines (1450)
Venture capital (188)
Weight loss (686)
Wet AMD (7)
Women's health (190)
Women in leadership (2)
Worklife (28)
Date
Today (147)
Last 7 days (888)
Last 30 days (4117)
Last 365 days (34032)
2026 (30937)
2025 (33214)
2024 (37866)
2023 (42564)
2022 (53927)
2021 (58720)
2020 (57662)
2019 (51334)
2018 (39119)
2017 (37186)
2016 (38329)
2015 (44431)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1310)
Alabama (118)
Alaska (7)
Arizona (494)
Arkansas (17)
Asia (53216)
Australia (9371)
California (17404)
Canada (4788)
China (2071)
Colorado (773)
Connecticut (777)
Delaware (549)
Europe (122889)
Florida (2637)
Georgia (567)
Hawaii (5)
Idaho (70)
Illinois (1504)
India (158)
Indiana (786)
Iowa (37)
Japan (785)
Kansas (160)
Kentucky (69)
Louisiana (73)
Maine (99)
Maryland (2053)
Massachusetts (12597)
Michigan (477)
Minnesota (957)
Mississippi (8)
Missouri (191)
Montana (38)
Nebraska (31)
Nevada (208)
New Hampshire (94)
New Jersey (4607)
New Mexico (38)
New York (4533)
North Carolina (2250)
North Dakota (14)
Northern California (8889)
Ohio (544)
Oklahoma (32)
Oregon (55)
Pennsylvania (3332)
Puerto Rico (38)
Rhode Island (66)
South America (1674)
South Carolina (105)
South Dakota (2)
Southern California (6940)
Tennessee (289)
Texas (2895)
United States (61685)
Utah (529)
Vermont (2)
Virginia (436)
Washington D.C. (89)
Washington State (1389)
West Virginia (4)
Wisconsin (200)
Wyoming (6)
There are 898,308 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SynAct Pharma Draws Down the Second Tranche of The Financing Facility with Fenja Capital II A/S And Resolves on A Directed Issue of Convertibles to Fenja
November 18, 2026
·
4 min read
Press Releases
Adaptive Biotechnologies Highlights clonoSEQ’s Central Role in Advancing MRD-Guided Care Across Hematology at ASH 2026
November 18, 2026
·
6 min read
Press Releases
Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Increased Dose of 15 mg/kg in Entrada Therapeutics’ ELEVATE-45-201 Study
November 18, 2026
·
7 min read
Press Releases
Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
November 18, 2026
·
5 min read
Press Releases
Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS
November 18, 2026
·
9 min read
Press Releases
Novo Nordisk Foundation commits US$60 million to strengthen CARB-X efforts against antimicrobial resistance
November 18, 2026
·
12 min read
Press Releases
Zealand Pharma announces initiation of the Phase 2 ZYNERGY trial of petrelintide co-administered with enicepatide in people with obesity or overweight
November 18, 2026
·
8 min read
Podcast
Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
The FDA declined to approve Summit Therapeutics’ Akeso-partnered ivonescimab, putting other PD-1/VEGF drug developers on notice; Isomorphic bagged a $5 billion series C, the largest in biotech history; ObesityWeek and Clinical Trials on Alzheimer’s Disease conferences in full swing.
November 18, 2026
·
2 min read
·
Jef Akst
Mergers & acquisitions
5 acquisitions that forced Big Pharmas to co-parent
Acquiring a biotech with an existing Big Pharma partner can impose financial and strategic constraints around data sharing and milestone and royalty payments—but it is “rarely a deal-breaker,” according to one biotech consultant.
November 18, 2026
·
8 min read
·
Tristan Manalac
Career Advice
Opinion: Stop trying to recreate your last company
Your previous employer may have set a high standard. Executive coach Angela Justice explains how holding every company to it can distort your judgment and undermine your influence.
November 18, 2026
·
4 min read
·
Angela Justice
1 of 89,831
Next